Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.35 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.34 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.34 |
| ▸ | AURKA | O14965 | 1/20 | 0.34 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.34 |
| ▸ | JAK2 | O60674 | 1/20 | 0.34 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.34 |
| ▸ | PAK4 | O96013 | 1/20 | 0.34 |
| ▸ | ABL1 | P00519 | 1/20 | 0.34 |
| ▸ | LCK | P06239 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | CSF1R | P07333 | 1/20 | 0.34 |
| ▸ | RET | P07949 | 1/20 | 0.34 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | FLT1 | P17948 | 1/20 | 0.34 |
| ▸ | LTK | P29376 | 1/20 | 0.34 |
| ▸ | KDR | P35968 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29935566 | 0.87 | IDO1 (0.33) | IDO1CYP3A4HDAC8CYP2C19KDM1A | |
| SCHEMBL28759287 | 0.84 | IDO1 (0.34) | IDO1CYP3A4HDAC8CYP2C19KDM1A | |
| SCHEMBL31032205 | 0.83 | PLG (0.41) | IDO1ALDH1A1CYP3A4HDAC8CYP2C19 | |
| SCHEMBL17000191 | 0.83 | IDO1 (0.33) | IDO1CYP3A4HDAC8CYP2C19KDM1A | |
| SCHEMBL29867137 | 0.83 | PLG (0.41) | IDO1ALDH1A1CYP3A4HDAC8CYP2C19 | |
| SCHEMBL568609 | 0.83 | PLG (0.41) | IDO1ALDH1A1CYP3A4HDAC8CYP2C19 | |
| SCHEMBL3466298 | 0.83 | ADRB2 (0.35) | IDO1MAP4K4GSK3AGSK3BCDK9 | |
| SCHEMBL3464147 | 0.83 | ADRB2 (0.35) | IDO1MAP4K4GSK3AGSK3BCDK9 | |
| SCHEMBL21200276 | 0.83 | PLG (0.41) | IDO1ALDH1A1CYP3A4HDAC8CYP2C19 | |
| SCHEMBL14211416 | 0.83 | ADRB2 (0.35) | IDO1MAP4K4GSK3AGSK3BCDK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3960747-B1 | ORGANOMETALLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO LTD (KR) | 2025-12-10 | — | — | EP | disclosed |
| US-12492218-B2 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-12-09 | — | — | US | disclosed |
| US-12448402-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-21 | — | — | US | disclosed |
| EP-4016656-B1 | ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME, AND DIAGNOSTIC COMPOSITION INCLUDING THE ORGANOMETALLIC COMPOUND | SAMSUNG ELECTRONICS CO LTD (KR) | 2025-09-03 | — | — | EP | disclosed |
| US-12391714-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-08-19 | — | — | US | disclosed |
| CN-116553993-B | Method for producing alpha-olefin | 中化学科学技术研究有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118955569-A | Organic electroluminescent material and organic electroluminescent device | 吉林奥来德光电材料股份有限公司 | 2024-11-15 | — | — | CN | disclosed |
| US-12004416-B2 | Organometallic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2024-06-04 | — | — | US | disclosed |
| CN-117659088-A | Organic ligand containing NPN and PNP structures, preparation method thereof, catalyst and ethylene oligomerization method | 中化学科学技术研究有限公司 | 2024-03-08 | — | — | CN | disclosed |
| CN-117659087-A | Binuclear metal complex containing NP structure, preparation method and application thereof | 中化学科学技术研究有限公司 | 2024-03-08 | — | — | CN | disclosed |
| US-8034811-B2 | Hydroxamic acid esters and pharmaceutical use thereof | LEO PHARMA A/S (DK) | 2011-10-11 | — | — | US | disclosed |
| US-20110224190-A1 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | INCYTE CORPORATION | 2011-09-15 | — | — | US | disclosed |
| US-20110224190-A1 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | INCYTE CORPORATION | 2011-09-15 | — | — | US | disclosed |
| US-20100323887-A1 | MESOIONIC PESTICIDES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-12-23 | — | — | US | disclosed |
| US-20100113439-A1 | Antifungal agents | MERCK & CO., INC. (US) | 2010-05-06 | — | — | US | disclosed |
| US-20090102363-A1 | METAL COMPLEX COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20090102363-A1 | METAL COMPLEX COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20070244117-A1 | Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof | LEO PHARMA A/S (DK) | 2007-10-18 | — | — | US | disclosed |
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | SCHERING CORPORATION | 2007-06-21 | — | — | US | disclosed |
| US-7220735-B2 | Benzimidazolone histamine H3 antagonists | SCHERING CORPORATION (US) | 2007-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12492218-B2 | Organometallic compound, organic light-emitting device including the same, and electronic apparatus including the organic light-emitting device | L1CAM, FOXM1, CCNT1 | LMNA 612/4885IDO1 1289/4885CHRNA7 3113/4885 |
| US-20070142369-A1 | Combination of an H3 antagonist/inverse agonist and an appetite suppressant | CNR2, GPR119, GLP1R | LMNA 4032/4885IDO1 183/4885CHRNA7 167/4885 |
| US-20090102363-A1 | METAL COMPLEX COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | EPCAM, L1CAM, EMC2 | LMNA 1800/4885IDO1 3194/4885CHRNA7 333/4885 |
| US-20100113439-A1 | Antifungal agents | GMDS, GBA3, UGGT1 | LMNA 3066/4885IDO1 857/4885CHRNA7 4618/4885 |
| US-12448402-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | L1CAM, NOM1, LEF1 | LMNA 1217/4885IDO1 795/4885CHRNA7 4169/4885 |
| US-20100323887-A1 | MESOIONIC PESTICIDES | DDT, CHRM1, CHRM3 | LMNA 4228/4885IDO1 31/4885CHRNA7 86/4885 |
| US-12004416-B2 | Organometallic compound and organic light-emitting device including the same | L1CAM, FOXM1, LEF1 | LMNA 1654/4885IDO1 690/4885CHRNA7 3541/4885 |
| US-12391714-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | L1CAM, FOXM1, CYBA | LMNA 1153/4885IDO1 513/4885CHRNA7 2519/4885 |
| US-20070244117-A1 | Novel Hydroxamic Acid Esters and Pharmaceutical Use Thereof | F9, F12, HDAC9 | LMNA 3439/4885IDO1 3029/4885CHRNA7 4641/4885 |
| US-20110224190-A1 | PIPERIDIN-4-YL AZETIDINE DERIVATIVES AS JAK1 INHIBITORS | JAK1, JAK2, JAK3 | LMNA 4748/4885IDO1 104/4885CHRNA7 4806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.